HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $9 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on LifeMD (NASDAQ:LFMD) and maintained a price target of $9.
August 11, 2023 | 5:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
LifeMD's stock may see positive movement due to the reiterated 'Buy' rating and maintained price target by HC Wainwright & Co.
Analyst ratings and price targets can significantly influence a stock's performance. In this case, the 'Buy' rating and $9 price target by HC Wainwright & Co. for LifeMD could lead to increased investor confidence and potentially positive stock movement in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100